New pill could tame rare blood disorder without chemotherapy
NCT ID NCT06456346
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This phase 3 trial compares bomedemstat, an experimental oral drug, to hydroxyurea (standard therapy) in 300 people with essential thrombocythemia who have not yet received cytoreductive treatment. The goal is to see if bomedemstat better controls platelet counts and prevents complications like blood clots or bleeding. Participants take capsules daily for at least a year, with regular monitoring.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bomedemstat (also called MK-3543)
- What this could lead to
- If bomedemstat works better than hydroxyurea, it could offer a new first-choice treatment to control platelet counts and reduce the risk of blood clots or bleeding in people with essential thrombocythemia.
- What could go wrong
- This is a phase 3 trial, so results are not yet known. Bomedemstat may not prove superior to hydroxyurea, and side effects could limit its use. The study is still recruiting, so findings are years away.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL THROMBOCYTHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aarhus Universitetshospital, Skejby-Blodsygdomme ( Site 0324)
Aarhus, Central Jutland, 8200, Denmark
-
Akademiska sjukhuset ( Site 0545)
Uppsala, Uppsala County, 751 85, Sweden
-
Anhui Provincial Hospital ( Site 0657)
Hefei, Anhui, 230001, China
-
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 0502)
Ankara, 06800, Turkey (Türkiye)
-
Ankara UTF Cebeci Arastırma ve Uygulama Hastanesi ( Site 0511)
Ankara, 6620, Turkey (Türkiye)
-
Antalya Egitim ve Arastırma Hastanesi ( Site 0508)
Antalya, 07100, Turkey (Türkiye)
-
Arthur J.E. Child Comprehensive Cancer Centre ( Site 0038)
Calgary, Alberta, T2N 5G2, Canada
-
Austin Health-Cancer Clinical Trials Centre ( Site 0206)
Heidelberg, Victoria, 3084, Australia
-
Azienda Ospedaliera Universitaria Careggi ( Site 0441)
Florence, Tuscany, 50134, Italy
-
Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo ( Site 0443)
Alessandria, 15121, Italy
-
Biocenter ( Site 0149)
Concepción, Biobio, 4070196, Chile
-
Boston Pilgrim Hospital ( Site 0525)
Boston, Lincolnshire, PE21 9QS, United Kingdom
-
Bradfordhill-Clinical Area ( Site 0142)
Santiago, Region M. de Santiago, 8420383, Chile
-
C.I.C.E. 9 de Julio ( Site 0104)
San Miguel de Tucumán, Tucumán Province, T4000IKO, Argentina
-
CHU Bordeaux Haut-Leveque-service de mèdecine interne et maladies infectieuses ( Site 0346)
Pessac, Aquitaine, 33600, France
-
Carmel Hospital ( Site 0426)
Haifa, 3436212, Israel
-
Centre Hospitalier Régional Universitaire de Tours - Hôpital-Hématologie et Thérapie Cellulaire ( Site 0342)
Tours, Indre-et-Loire, 37000, France
-
Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren ( Site 0344)
Limoges, Haute-Vienne, 87042, France
-
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu ( Site 0347)
Nantes, Pays de la Loire Region, 44093, France
-
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet-Hematology ( Site 0349)
Nice, Alpes-Maritimes, 06202, France
-
Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 0037)
Greenfield Park, Quebec, J4V 2H1, Canada
-
Centro de Investigacion Clinica de Oaxaca ( Site 0181)
Oaxaca City, Oaxaca, 68020, Mexico
-
Chang Gung Medical Foundation-Linkou Branch ( Site 0243)
Taoyuan, 33305, Taiwan
-
Chang Gung Memorial Hospital- Chiayi ( Site 0242)
Chiayi City, Chiayi, 613, Taiwan
-
Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0369)
Berlin, 13353, Germany
-
Chinese Academy of medical science, Peking Union Medical College Hospital(Dongdan) ( Site 0675)
Beijing, Beijing Municipality, 100730, China
-
Chongqing University Cancer Hospital ( Site 0666)
Chongqing, Chongqing Municipality, 400030, China
-
Clinica Universidad de Navarra-Hematology Department ( Site 0485)
Madrid, Madrid, Comunidad de, 28027, Spain
-
Clínica Alemana de Santiago ( Site 0143)
Santiago, Region M. de Santiago, 7650568, Chile
-
Clínica Inmunocel ( Site 0147)
Santiago, Region M. de Santiago, 7580206, Chile
-
Clínica de Nefrología, Urología y Enfermedades Cardiovasculares ( Site 0105)
Santa Fe, 3000, Argentina
-
Debreceni Egyetem Klinikai Kozpont-Belgyógyászati Klinika (Haematologia) ( Site 0402)
Debrecen, 4032, Hungary
-
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi-Hemotology ( Site 0510)
Ankara, 06200, Turkey (Türkiye)
-
Duke University Health System (DUHS) ( Site 0012)
Durham, North Carolina, 27710, United States
-
Ege Universitesi Hastanesi ( Site 0503)
Bornova, İzmir, 35100, Turkey (Türkiye)
-
Ehime University Hospital ( Site 0612)
Tōon, Ehime, 791-0295, Japan
-
Exempla Lutheran Medical Center ( Site 0014)
Golden, Colorado, 80401, United States
-
FALP-UIDO ( Site 0148)
Santiago, Region M. de Santiago, 7500921, Chile
-
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico ( Site 0447)
Milan, 20122, Italy
-
Fondazione IRCCS Policlinico San Matteo-Oncology ( Site 0444)
Pavia, 27100, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 0445)
Roma, 00168, Italy
-
Freeman Hospital ( Site 0532)
Newcastle upon Tyne, NE7 7DN, United Kingdom
-
Fujita Health University Hospital ( Site 0613)
Toyoake, Aichi-ken, 470-1192, Japan
-
Fukushima Medical University Hospital ( Site 0616)
Fukushima, 960-1295, Japan
-
Fundacion Colombiana de Cancerología Clinica Vida ( Site 0164)
Medellín, Antioquia, 050030, Colombia
-
Galilee Medical Center ( Site 0431)
Nahariya, 2201202, Israel
-
Glan Clwyd Hospital ( Site 0528)
Bodelwyddan, Denbighshire, LL18 5UJ, United Kingdom
-
Gloucestershire Royal Hospital ( Site 0521)
Gloucester, Gloucestershire, Gl1 3NN, United Kingdom
-
Guy's & St Thomas' NHS Foundation Trust ( Site 0523)
London, London, City of, SE1 9RT, United Kingdom
-
HENRI MONDOR HOSPITAL ( Site 0348)
Créteil, Val-de-Marne, 94010, France
-
HOSPITAL CLÍNIC DE BARCELONA ( Site 0481)
Barcelona, Catalonia, 08036, Spain
-
Hacettepe Universite Hastaneleri-Department of Hematology ( Site 0505)
Ankara, 06230, Turkey (Türkiye)
-
Hadassah Medical Center ( Site 0424)
Jerusalem, 9112001, Israel
-
Hammersmith Hospital ( Site 0533)
London, London, City of, W12 OHS, United Kingdom
-
Henan Cancer Hospital-hematology department ( Site 0644)
Zhengzhou, Henan, 450008, China
-
Higiea Oncologia ( Site 0184)
Mexico City, Mexico City, 11819, Mexico
-
Hokkaido University Hospital ( Site 0601)
Sapporo, Hokkaido, 060-8648, Japan
-
Hopital Saint-Louis ( Site 0341)
Paris, 75010, France
-
Hospital Costa del Sol-Hematology Service ( Site 0493)
Marbella, Malaga, 29603, Spain
-
Hospital Germans Trias i Pujol-Instituto Catalán de Oncología de Badalona ( Site 0490)
Badalona, Barcelona, 08916, Spain
-
Hospital Italiano de Buenos Aires ( Site 0102)
ABB, Buenos Aires F.D., C1199ABB, Argentina
-
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 0489)
Barcelona, 08035, Spain
-
Hospital Universitario 12 de Octubre ( Site 0494)
Madrid, 28041, Spain
-
Hospital Universitario Austral ( Site 0101)
Pilar, Buenos Aires, B1629AHJ, Argentina
-
Hospital Universitario Marqués de Valdecilla-Haematology ( Site 0486)
Santander, Cantabria, 39008, Spain
-
Hospital Universitario Ramón y Cajal-Hematology ( Site 0484)
Madrid, Madrid, Comunidad de, 28034, Spain
-
Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca-Hematology ( Site 0488)
Salamanca, 37007, Spain
-
Huashan Hospital, Fudan University ( Site 0669)
Shanghai, Shanghai Municipality, 200040, China
-
Hôpital de la Conception ( Site 0351)
Marseille, Bouches-du-Rhone, 13005, France
-
IC La Serena Research ( Site 0150)
La Serena, Coquimbo Region, 1720430, Chile
-
IMAT S.A.S ( Site 0162)
Montería, Departamento de Córdoba, 230002, Colombia
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 0446)
Bologna, 40138, Italy
-
Institut Català d'Oncologia - L'Hospitalet ( Site 0482)
L'Hospitalet de Llobregat, Barcelona, 08908, Spain
-
Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE ( Site 0352)
Toulouse, Haute-Garonne, 31059, France
-
Institute of hematology&blood disease hospital-Hematology ( Site 0641)
Tianjin, Tianjin Municipality, 301636, China
-
Jinan Central Hospital ( Site 0667)
Jinan, Shandong, 250013, China
-
Juntendo University Hospital ( Site 0611)
Bunkyo-ku, Tokyo, 113-8431, Japan
-
Kanazawa University Hospital ( Site 0614)
Kanazawa, Ishikawa-ken, 920-8641, Japan
-
Kansai Medical University Hospital ( Site 0607)
Hirakata, Osaka, 573-1191, Japan
-
Karolinska Universitetssjukhuset Huddinge ( Site 0541)
Huddinge, Stockholm County, 141 86, Sweden
-
Kindai University Hospital ( Site 0600)
Sakai, Osaka, 590-0197, Japan
-
Kobe City Medical Center General Hospital ( Site 0603)
Kobe, Hyōgo, 650-0047, Japan
-
Kocaeli Üniversitesi-Hematology ( Site 0506)
Kocaeli, 41380, Turkey (Türkiye)
-
Kyushu University Hospital ( Site 0605)
Fukuoka, 812-8582, Japan
-
Levine Cancer Institute ( Site 0009)
Charlotte, North Carolina, 28204, United States
-
Lincoln County Hospital ( Site 0535)
Lincoln, Great Britain, LN2 5QY, United Kingdom
-
Los Angeles Cancer Network ( Site 0025)
Glendale, California, 91206, United States
-
Los Cobos Medical Center ( Site 0165)
Bogotá, Bogota D.C., 110121, Colombia
-
Medipol Mega Universite Hastanesi ( Site 0504)
Istanbul, 34214, Turkey (Türkiye)
-
Medivest Centro de Investigación Integral ( Site 0183)
Chihuahua City, Chihuahua, 31203, Mexico
-
Medizinische Hochschule Hannover ( Site 0371)
Hanover, Lower Saxony, 30625, Germany
-
Mie University Hospital ( Site 0615)
Tsu, Mie-ken, 514-8507, Japan
-
Monash Health-Haematology Research ( Site 0202)
Clayton, Victoria, 3168, Australia
-
National Cheng Kung University Hospital-Clinical Trial Center ( Site 0245)
Tainan, 704, Taiwan
-
National Hospital Organization Sendai Medical Center ( Site 0617)
Sendai, Miyagi, 983-8520, Japan
-
National Taiwan University Hospital ( Site 0241)
Taipei, 10002, Taiwan
-
Nippon Medical School Hospital ( Site 0608)
Tokyo, 113-8603, Japan
-
Odense Universitetshospital-Department of Hematology ( Site 0325)
Odense C, Region Syddanmark, 5000, Denmark
-
Okayama University Hospital ( Site 0604)
Okayama, 700-8558, Japan
-
Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8005)
Eugene, Oregon, 97401, United States
-
Ondokuz Mayıs Universitesi-hematology ( Site 0507)
Samsun, 55139, Turkey (Türkiye)
-
Optum Care Cancer Center ( Site 0053)
Las Vegas, Nevada, 89102, United States
-
Ordensklinikum Linz GmbH Elisabethinen ( Site 0562)
Linz, Upper Austria, 4020, Austria
-
Oregon Health & Science University ( Site 0018)
Portland, Oregon, 97239, United States
-
Ospedale di Circolo e Fondazione Macchi Varese ( Site 0442)
Varese, 21100, Italy
-
Palo Verde Cancer Specialists ( Site 0052)
Glendale, Arizona, 85304, United States
-
Parkview Research Center at Parkview Regional Medical Center ( Site 0006)
Fort Wayne, Indiana, 46845, United States
-
Peking University Third Hospital-Hematology ( Site 0659)
Beijing, Beijing Municipality, 100191, China
-
Petz Aladar Egyetemi Oktato Korhaz-Hematológia ( Site 0405)
Győr, Győr-Moson-Sopron, 9024, Hungary
-
Pratia Onkologia Katowice ( Site 0461)
Katowice, Silesian Voivodeship, 40-519, Poland
-
Queen Mary Hospital ( Site 0221)
Hksar, Hong Kong
-
Rabin Medical Center ( Site 0425)
Petah Tikva, 4941492, Israel
-
Rambam Health Care Campus ( Site 0429)
Haifa, 3109601, Israel
-
Rigshospitalet-Hematology - CTU ( Site 0321)
Copenhagen, Capital Region, 2100, Denmark
-
Roskilde Sygehus-Department of Hematology ( Site 0323)
Roskilde, Region Sjælland, 4000, Denmark
-
Royal Adelaide Hospital-Haematology Clinical Trials Unit ( Site 0203)
Adelaide, South Australia, 5000, Australia
-
Royal Gwent Hospital ( Site 0524)
Newport, NP20 2EF, United Kingdom
-
Royal Perth Hospital-Haematology ( Site 0204)
Perth, Western Australia, 6000, Australia
-
Sahlgrenska Universitetssjukhuset-Department of hematology and coagulation ( Site 0543)
Gothenburg, Västra Götaland County, 413 45, Sweden
-
Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie-Oddział Hematoonkologii, Transplantacji Szp ( Site 0463)
Lublin, Lublin Voivodeship, 20-081, Poland
-
Shaanxi provincial people's hospital ( Site 0652)
Xi'an, Shaanxi, 710068, China
-
Sheba Medical Center ( Site 0428)
Ramat Gan, 5265601, Israel
-
Skånes Universitetssjukhus Lund-Department of Hematology ( Site 0544)
Lund, Skåne County, 22185, Sweden
-
Somogy Vármegyei Kaposi Mór Oktató Kórház-Haematológiai osztály ( Site 0406)
Kaposvár, Somogy County, 7400, Hungary
-
Soroka Medical Center ( Site 0427)
Beersheba, 8410101, Israel
-
Sourasky Medical Center ( Site 0422)
Tel Aviv, 6423906, Israel
-
Southern Medical University Nanfang Hospital-Department of Hematopathology ( Site 0655)
Guangzhou, Guangdong, 510515, China
-
Stanford Cancer Center ( Site 0024)
Palo Alto, California, 94304, United States
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University-hematology department ( Site 0668)
Guangzhou, Guangdong, 510120, China
-
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Hematologii i Transplantacji S ( Site 0466)
Kielce, Świętokrzyskie Voivodeship, 25-734, Poland
-
Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókór-Haematológia osztály ( Site 0404)
Nyíregyháza, Szabolcs-Szatmár-Bereg, 4400, Hungary
-
Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Belgyógyászati Klinika ( Site 0407)
Szeged, Csongrád megye, 6725, Hungary
-
Texas Oncology - DFW ( Site 8006)
Dallas, Texas, 75246, United States
-
Texas Oncology - Gulf Coast ( Site 8008)
Webster, Texas, 77598, United States
-
Texas Oncology - West Texas ( Site 8003)
Amarillo, Texas, 79124, United States
-
The First Affiliated Hospital of Soochow University ( Site 0676)
Suzhou, Jiangsu, 215006, China
-
The First Affiliated hospital of Xiamen University ( Site 0658)
Xiamen, Fujian, 361003, China
-
The First Afflilated Hospital of Bengbu Medical College ( Site 0651)
Bengbu, Anhui, 233004, China
-
The First Hospital of Hebei Medical University ( Site 0649)
Shijiazhuang, Hebei, 050031, China
-
The First Hospital of Jilin University-Hematology ( Site 0672)
Changchun, Jilin, 130021, China
-
The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 0645)
Nanchang, Jiangxi, 330209, China
-
The Ohio State University Wexner Medical Center ( Site 0028)
Columbus, Ohio, 43210, United States
-
The Second Affiliated Hospital of Fujian Medical University ( Site 0671)
Quanzhou, Fujian, 362000, China
-
The Second Afilliated Hospital of Hebei Medical University ( Site 0650)
Shijiazhuang, Hebei, 050000, China
-
The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 0646)
Hangzhou, Zhejiang, 310000, China
-
Trakya University Medical Faculty Hospital-Hematology ( Site 0501)
Edirne, 22030, Turkey (Türkiye)
-
TriStar Bone Marrow ( Site 7000)
Nashville, Tennessee, 37203, United States
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0642)
Wuhan, Hubei, 430022, China
-
Universitaetsklinikum Essen ( Site 0366)
Essen, North Rhine-Westphalia, 45147, Germany
-
Universitetssjukhuset Örebro ( Site 0542)
Örebro, Örebro County, 701 85, Sweden
-
University College London Hospital ( Site 0527)
London, London, City of, NW1 2PG, United Kingdom
-
University of Michigan ( Site 0003)
Ann Arbor, Michigan, 48109, United States
-
University of Miyazaki Hospital ( Site 0609)
Miyazaki, 889-1692, Japan
-
University of Texas Health Science Center at San Antonio ( Site 0021)
San Antonio, Texas, 78229, United States
-
University of Texas MD Anderson Cancer Center ( Site 0026)
Houston, Texas, 77030, United States
-
University of Virginia ( Site 0020)
Charlottesville, Virginia, 22908, United States
-
University of Yamanashi Hospital ( Site 0606)
Chūō, Yamanashi, 409-3898, Japan
-
Universitätsklinikum Aachen ( Site 0367)
Aachen, North Rhine-Westphalia, 52074, Germany
-
Universitätsklinikum Halle ( Site 0361)
Halle, Saxony-Anhalt, 06120, Germany
-
Universitätsklinikum Jena-Klinik für Innere Medizin II, Abt. Hämatologie und Internistische Onkolog ( Site 0364)
Jena, Thuringia, 07747, Germany
-
Universitätsmedizin Johannes Gutenberg Universität Mainz-3. Medizinische Klinik und Poliklinik ( Site 0365)
Mainz, Rhineland-Palatinate, 55131, Germany
-
VCU Health Adult Outpatient Pavillion ( Site 0008)
Richmond, Virginia, 23219, United States
-
VK&K Studien GbR ( Site 0370)
Landshut, Bavaria, 84036, Germany
-
Wake Forest Baptist Health-Internal Medicine, Section on Hematology & Oncology ( Site 0013)
Winston-Salem, North Carolina, 27157, United States
-
West China Hospital, Sichuan University ( Site 0661)
Chengdu, Sichuan, 610041, China
-
Westmead Hospital ( Site 0201)
Westmead, New South Wales, 2115, Australia
-
Yale University School of Medicine ( Site 0051)
New Haven, Connecticut, 06510, United States
-
Yitzhak Shamir Medical Center. ( Site 0421)
Ẕerifin, 7033001, Israel
-
Zhejiang University School of Medicine-The Fourth Affiliated Hospital ( Site 0662)
Yiwu, Zhejiang, 322000, China
-
Zhongshan Hospital,Fudan University-Hematology ( Site 0674)
Shanghai, Shanghai Municipality, 200032, China
-
centre hospitalier lyon sud ( Site 0343)
Pierre-Bénite, Rhone, 69310, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Dual-Action pill tame bone marrow tumors?
- Can a biologic drug outperform standard therapy for a rare blood cancer?
- New drug candidate targets Hard-to-Treat blood cancers
- Blood clot risk in rare disease: could a higher dose of clopidogrel offer better protection?
- New oral drug could tame overactive bone marrow in rare blood cancers
- New hope for rare blood cancer: targeted drug enters final testing